The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial-Reference-Cited by-同舟云学术

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

Published:2015-03-20 Issue:5 Volume:61 Page:1555-1564
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Adams Leon A.¹²,Crawford Darrell H.³⁴,Stuart Katherine⁴,House Michael J.⁵,St. Pierre Timothy G.⁵,Webb Malcolm⁶,Ching Helena L.I.²,Kava Jenny⁷,Bynevelt Michael⁸,MacQuillan Gerry C.¹²,Garas George¹²,Ayonrinde Oyekoya T.⁷⁹¹⁰,Mori Trevor A.¹,Croft Kevin D.¹,Niu Xianwa¹,Jeffrey Gary P.¹²,Olynyk John K.⁷⁹¹⁰

Affiliation:

1. School of Medicine & Pharmacology, University of Western Australia; Crawley Australia

2. Department of Gastroenterology & Hepatology; Sir Charles Gairdner Hospital; Perth Australia

3. School of Medicine, University of Queensland; Brisbane Australia

4. Department of Gastroenterology; Greenslopes Private Hospital; Brisbane Australia

5. School of Physics, University of Western Australia; Crawley Australia

6. Department of Hematology; Fremantle Hospital; Fremantle Australia

7. Department of Gastroenterology; Fremantle Hospital; Fremantle Australia

8. Department of Radiology; Sir Charles Gairdner Hospital; Perth Australia

9. Faculty of Health Sciences; Curtin University; Perth Australia

10. Institute for Immunology and Infectious Diseases, Murdoch University; Perth Australia

Funder

Western Australian Department of Health

Publisher

Wiley

Subject

Hepatology

Reference46 articles.

1. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

2. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease;Nelson;Hepatology,2011

3. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target;Dongiovanni;J Hepatol,2011

4. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease;Valenti;Gastroenterology,2010

5. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death;Imeryuz;J Hepatol,2007

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferritin—a promising biomarker in MASLD;Gut;2024-03-27

2. Exploring the interactions between metabolic dysfunction-associated fatty liver disease and micronutrients: from molecular mechanisms to clinical applications;Frontiers in Nutrition;2024-03-14

3. Difference in the Mechanism of Iron Overload–Enhanced Acute Hepatotoxicity Induced by Thioacetamide and Carbon Tetrachloride in Rats;Toxicologic Pathology;2024-01

4. Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes;Exploration of Drug Science;2023-08-28

5. Secondary Iron Overload and the Liver: A Comprehensive Review;Journal of Clinical and Translational Hepatology;2023-02-01